Hims & Hers Health financials
$28.70−0.28%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | $2.35B | $1.48B | $872.0M | $526.9M | $271.9M |
| Gross profit | $1.73B | $1.17B | $714.9M | $408.7M | $204.5M |
| Gross margin | 73.8% | 79.5% | 82.0% | 77.6% | 75.2% |
| Operating income | $105.6M | $61.9M | -$29.5M | -$68.7M | -$115.0M |
| Net income | $128.4M | $126.0M | -$23.5M | -$65.7M | -$107.7M |
| Net margin | 5.5% | 8.5% | −2.7% | −12.5% | −39.6% |
| Diluted EPS | $0.51 | $0.53 | $-0.11 | $-0.32 | $-0.58 |
| EBITDA | $160.1M | $79.0M | -$19.9M | -$61.2M | -$111.0M |
| Operating cash flow | $300.0M | $251.1M | $73.5M | -$26.5M | -$34.4M |
| Free cash flow | $57.4M | $198.3M | $47.0M | -$33.8M | -$39.4M |
| Diluted shares | 258.2M | 236.8M | 209.3M | 204.5M | 186.8M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $228.6M | $220.6M | $96.7M | $46.8M | $71.8M |
| Short-term investments | $348.9M | $79.7M | $124.3M | $132.9M | $175.5M |
| Total debt | $972.6M | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $2.15B | $707.5M | $441.2M | $366.3M | $420.6M |
| Total liabilities | $1.61B | $230.8M | $97.2M | $54.6M | $86.0M |
| Shareholders' equity | $540.9M | $476.7M | $344.0M | $311.7M | $334.6M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology